{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T06:13:02Z","timestamp":1741068782292,"version":"3.38.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"DOI":"10.7759\/cureus.79991","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T03:31:21Z","timestamp":1741059081000},"source":"Crossref","is-referenced-by-count":0,"title":["Rapid Relief of Gastroesophageal Reflux Disease (GERD) Symptoms With Sodium Alginate Antacid Suspension: An Indian Real-World Evidence Study"],"prefix":"10.7759","author":[{"given":"Thoguluva S","family":"Chandrasekhara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh Chandra","family":"Patra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit","family":"Shimpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyan","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh R","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onkar C","family":"Swami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Gastroesophageal reflux disease (GERD)","volume":"115","author":"Clarrett DM","year":"2018","unstructured":"Clarrett DM, Hachem C. Gastroesophageal reflux disease (GERD). Mo Med. 2018, 115:214-8.","journal-title":"Mo Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/aoe-20-80","article-title":"A narrative review of the prevalence of gastroesophageal reflux disease (GERD)","volume":"5","author":"Boulton KH","year":"2022","unstructured":"Boulton KH, Dettmar PW. A narrative review of the prevalence of gastroesophageal reflux disease (GERD). Ann Esophagus. 2022, 5:1-10. 10.21037\/aoe-20-80","journal-title":"Ann Esophagus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-019-00979-y","article-title":"Indian consensus on gastroesophageal reflux disease in adults: a position statement of the Indian Society of Gastroenterology","volume":"38","author":"Bhatia SJ","year":"2019","unstructured":"Bhatia SJ, Makharia GK, Abraham P, et al.. Indian consensus on gastroesophageal reflux disease in adults: a position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019, 38:411-40. 10.1007\/s12664-019-00979-y","journal-title":"Indian J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-020-01104-0","article-title":"Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: a\u00a0meta-analysis and meta-regression study","volume":"40","author":"Rai S","year":"2021","unstructured":"Rai S, Kulkarni A, Ghoshal UC. Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: a\u00a0meta-analysis and meta-regression study. Indian J Gastroenterol. 2021, 40:209-19. 10.1007\/s12664-020-01104-0","journal-title":"Indian J Gastroenterol"},{"key":"ref5","article-title":"API-ISG consensus guidelines for management of gastrooesophageal reflux disease","volume":"68","author":"Bhatia S","year":"2020","unstructured":"Bhatia S, Pareek KK, Kumar A, et al.. API-ISG consensus guidelines for management of gastrooesophageal reflux disease. J Assoc Physicians India. 2020, 68:69-80.","journal-title":"J Assoc Physicians India"},{"key":"ref6","article-title":"Gastroesophageal Reflux Disease","author":"Antunes C","year":"2023","unstructured":"Antunes C, Aleem A, Curtis SA. Gastroesophageal Reflux Disease. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-90","article-title":"Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study","volume":"7","author":"Gisbert JP","year":"2009","unstructured":"Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agr\u00e9us L, Jablonowski H, Nuevo J. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes. 2009, 7:90. 10.1186\/1477-7525-7-90","journal-title":"Health Qual Life Outcomes"},{"key":"ref8","unstructured":"Standards of care for GERD. (2016). Accessed. June 4, 2024: https:\/\/www.uspharmacist.com\/article\/standards-of-care-for-gerd."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9270(03)00013-3","article-title":"Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients","volume":"98","author":"Bytzer P","year":"2003","unstructured":"Bytzer P . Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol. 2003, 98:S31-9. 10.1016\/s0002-9270(03)00013-3","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.124024.1","article-title":"An expert opinion on antacids: a review of its pharmacological properties and therapeutic efficacy","volume":"11","author":"Shetty B","year":"2022","unstructured":"Shetty B, Vishwanath MK. An expert opinion on antacids: a review of its pharmacological properties and therapeutic efficacy. F1000Res. 2022, 11:1057. 10.12688\/f1000research.124024.1","journal-title":"F1000Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/app.48012","article-title":"Raft\u2010forming polysaccharides for the treatment of gastroesophageal reflux disease (GORD): systematic review","volume":"136","author":"Yousaf M","year":"2019","unstructured":"Yousaf M, Nirwan JS, Smith AM, et al.. Raft\u2010forming polysaccharides for the treatment of gastroesophageal reflux disease (GORD): systematic review. J Appl Polym Sci. 2019, 136:48012. 10.1002\/app.48012","journal-title":"J Appl Polym Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/dow020","article-title":"Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis","volume":"30","author":"Leiman DA","year":"2017","unstructured":"Leiman DA, Riff BP, Morgan S, et al.. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus. 2017, 30:1-9. 10.1093\/dote\/dow020","journal-title":"Dis Esophagus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.97","article-title":"Alginate rafts localize to the acid pocket and reduce acid reflux in GERD","volume":"10","author":"Leake I","year":"2013","unstructured":"Leake I. Alginate rafts localize to the acid pocket and reduce acid reflux in GERD. Nat Rev Gastroenterol Hepatol. 2013, 10:386. 10.1038\/nrgastro.2013.97","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.07.049","article-title":"Management of gastroesophageal reflux disease","volume":"154","author":"Gyawali CP","year":"2018","unstructured":"Gyawali CP, Fass R. Management of gastroesophageal reflux disease. Gastroenterology. 2018, 154:302-18. 10.1053\/j.gastro.2017.07.049","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12640","article-title":"Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease","volume":"39","author":"Thomas E","year":"2014","unstructured":"Thomas E, Wade A, Crawford G, Jenner B, Levinson N, Wilkinson J. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2014, 39:595-602. 10.1111\/apt.12640","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202011_23841","article-title":"Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Zhao CX","year":"2020","unstructured":"Zhao CX, Wang JW, Gong M. Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials. Eur Rev Med Pharmacol Sci. 2020, 24:11845-57. 10.26355\/eurrev_202011_23841","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12857","article-title":"Gaviscon Double Action Liquid (antacid and alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study","volume":"40","author":"De Ruigh A","year":"2014","unstructured":"De Ruigh A, Roman S, Chen J, Pandolfino JE, Kahrilas PJ. Gaviscon Double Action Liquid (antacid and alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study. Aliment Pharmacol Ther. 2014, 40:531-7. 10.1111\/apt.12857","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04678.x","article-title":"An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients","volume":"34","author":"Kwiatek MA","year":"2011","unstructured":"Kwiatek MA, Roman S, Fareeduddin A, Pandolfino JE, Kahrilas PJ. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients. Aliment Pharmacol Ther. 2011, 34:59-66. 10.1111\/j.1365-2036.2011.04678.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s1091-255x(98)80004-8","article-title":"Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease","volume":"2","author":"Velanovich V","year":"1998","unstructured":"Velanovich V. Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg. 1998, 2:141-5. 10.1016\/s1091-255x(98)80004-8","journal-title":"J Gastrointest Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321811","article-title":"Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial","volume":"71","author":"Kalapala R","year":"2022","unstructured":"Kalapala R, Karyampudi A, Nabi Z, et al.. Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial. Gut. 2022, 71:686-94. 10.1136\/gutjnl-2020-321811","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5056\/jnm19053","article-title":"Efficacy of S-pantoprazole 10 mg in the symptom control of non-erosive reflux disease: a phase iii placebo-controlled trial","volume":"27","author":"Cho YK","year":"2021","unstructured":"Cho YK, Choi MG, Park H, et al.. Efficacy of S-pantoprazole 10 mg in the symptom control of non-erosive reflux disease: a phase iii placebo-controlled trial. J Neurogastroenterol Motil. 2021, 27:223-30. 10.5056\/jnm19053","journal-title":"J Neurogastroenterol Motil"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i34.12277","article-title":"Heartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease","volume":"20","author":"Lee SW","year":"2014","unstructured":"Lee SW, Lien HC, Lee TY, Yang SS, Yeh HJ, Chang CS. Heartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease. World J Gastroenterol. 2014, 20:12277-82. 10.3748\/wjg.v20.i34.12277","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-60","article-title":"Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting","volume":"7","author":"Gisbert JP","year":"2009","unstructured":"Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agr\u00e9us L, Jablonowski H, Zapardiel J. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes. 2009, 7:60. 10.1186\/1477-7525-7-60","journal-title":"Health Qual Life Outcomes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00759.x","article-title":"Review article: alginate-raft formulations in the treatment of heartburn and acid reflux","volume":"14","author":"Mandel KG","year":"2000","unstructured":"Mandel KG, Daggy BP, Brodie DA, Jacoby HI. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 2000, 14:669-90. 10.1046\/j.1365-2036.2000.00759.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12318","article-title":"Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients","volume":"37","author":"Sweis R","year":"2013","unstructured":"Sweis R, Kaufman E, Anggiansah A, et al.. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther. 2013, 37:1093-102. 10.1111\/apt.12318","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326327-rapid-relief-of-gastroesophageal-reflux-disease-gerd-symptoms-with-sodium-alginate-antacid-suspension-an-indian-real-world-evidence-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T03:31:27Z","timestamp":1741059087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326327-rapid-relief-of-gastroesophageal-reflux-disease-gerd-symptoms-with-sodium-alginate-antacid-suspension-an-indian-real-world-evidence-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.79991","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}